688506 Sichuan Biokin Pharmaceutical
- 169.40
- -2.60-1.51%
Sichuan Biokin Pharmaceutical News
Legal opinion of JunHe Law Firm, Peking, regarding shareholder and actual controller of Sichuan BailiTianheng Pharmaceutical Co., Ltd. increasing their shareholding
Announcement on the completion of the implementation of the shareholding plan by the actual controller and chairman and general manager of Sichuan Bailitianheng Pharmaceutical Co., Ltd. and the results of the shareholding.
Sichuan Baili Tianteng Pharmaceutical Co., Ltd. voluntarily disclosed an announcement regarding the approval of Phase I clinical trial of injection BL-M14D1 (ADC) project for the treatment of advanced solid tumors.
Announcement from Sichuan BaiLiTianHeng Pharmaceutical Co., Ltd. regarding the submission of an application to the Hong Kong Stock Exchange for the issuance and listing of overseas listed foreign shares (H shares) and the publication of application materials.
Legal opinion on the second extraordinary general meeting of shareholders of Sichuan Bailitianheng Pharmaceutical Co., Ltd. in 2024 by JunHe (Chengdu) Law Firm, Peking.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. voluntarily disclosed the research results of the BL-B01D1 (EGFR×HER3 bispecific antibody-drug conjugate) project in the announcement published in The Lancet Oncology.
Announcement of the resolution of the second extraordinary shareholders' meeting of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. in 2024.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. voluntarily disclosed an announcement regarding the completion of the first patient enrollment in Phase III clinical trial of BL-B01D1 (EGFR x HER3-ADC) for locally advanced or metastatic triple-negative breast cancer.
2024 Second Extraordinary General Meeting of Shareholders' Materials for Sichuan Bailitianheng Pharmaceutical Co., Ltd.
Announcement on the Resolutions of the 13th Meeting of the Fourth Board of Supervisors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. regarding the change of board of directors' secretary.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Fund-raising Management System (Draft)
Overseas issuance of securities and related confidentiality and file management systems for Sichuan BailiTianheng Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Group Related Party Transaction Management System (Draft)
Draft of Working System for Independent Directors of Sichuan Bailitianheng Pharmaceutical Co., Ltd.
Draft of the Rules of Procedure of the Supervisory Board of Sichuan Bai Li Tian Heng Pharmaceutical Co., Ltd.
The Rules of Procedure for the Shareholders' Meeting of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. (Draft)
Board of directors meeting rules (draft) of Sichuan Bailitianheng Pharmaceutical Co., Ltd.
Draft of the Constitution of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement on the formulation of the "Articles of Association" and the relevant internal governance system applicable after the H-share issuance and listing by Sichuan Baili Pharmaceuticals Co., Ltd.
Analysis
Price Target
No Data
